Is a complete GH research report available?

No complete published report is available for Guardant Health, Inc. (GH) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Guardant Health, Inc. (GH)

NASDAQ: GH · USD

$144

-1.85 (-1.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first GH analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	19B
Revenue (ttm)	1.1B
Net income (ttm)	-433.2M
EPS (ttm)	-$3.40
Shares out	132.6M
Volume	1,579,436
Beta	1.59
Price target	$171	+19.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.1B
Net income (ttm): -433.2M
EPS (ttm): -$3.40
Market cap: 19B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All GH indicators

Market & fundamental data

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001576280
Company name	Guardant Health, Inc.
Country	United States
Country code	US
Cusip	40131M109
Employees	2,506
Employees Change	485%
Employees Change Percent	24
Enterprise value	$19.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
Industry PE	44.06
Industry PE Fwd	26.49
IPO Date	2018-10-04
Isin	US40131M1099
Last refreshed	2026-07-29
Market cap	$19B
Market cap category	Large-Cap
Price	$144
Price currency	USD
Rev Per Employee	431,051.48x
Sector	Healthcare
Sector PE	45.6
Sector PE Fwd	24.3
Sic	8071
Symbol	GH
Website	https://guardanthealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.27%
EV Sales Forward	14.12x
EV/Sales	18.19x
FCF yield	-1.25%
P/S ratio	17.63x
PS Forward	13.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-41.43%
EBITDA Margin	-37.83%
Gross margin	64.9%
Gross Profit	$701M
Gross Profit Growth	47.65%
Gross Profit Growth Q	52.81%
Gross Profit Growth3 Y	32.01%
Gross Profit Growth5 Y	28.89%
Net Income	$-433.2M
Net Income Growth Years	3%
Pretax Margin	-40.21%
Profit Margin	-40.1%
Profit Per Employee	$-172,862
ROA	-17.15
Roa5y	-15.9
ROCE	-27.57
ROIC	-21.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	223.58%
Cagr3y	56.57%
Cagr5y	5.55%
EPS Growth Years	3
Revenue Growth	39.56x
Revenue Growth Q	48.26x
Revenue Growth Quarters	31x
Revenue Growth Years	9x
Revenue Growth3 Y	30.85x
Revenue Growth5 Y	29.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.66
Assets	$1.9B
Cash	$1.1B
Current Assets	$1.4B
Current Liabilities	$292.1M
Debt	$1.7B
Equity	$-181.1M
Interest Coverage	-83.94
Liabilities	$2.1B
Long Term Assets	$547.8M
Long Term Liabilities	$1.8B
Net Cash	$-601.8M
Net Cash By Market Cap	$-3.16
Tangible Book Value	$-283.9M
Tangible Book Value Per Share	$-2.16
WACC	11.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.68
Inventory Turnover	4.71
Net Working Capital	$630,000
Quick ratio	4.25
Working Capital	$1.1B
Working Capital Turnover	$1.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.2%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	223.32%
200-day SMA	106
3Y total return	283.91%
50-day SMA	138.7
50-day SMA vs 200-day SMA	50over200
5Y total return	30.97%
All Time High	181.1
All Time High Change	-20.68%
All Time High Date	2021-02-12
All Time Low	15.81
All Time Low Change	808.41%
All Time Low Date	2024-04-19
ATR	7.37
Beta	1.59
Beta1y	1.38
Beta2y	1.32
Ch YTD	40.61
High	147.7
High52	174.1
High52 Date	2026-07-06
High52ch	-17.5%
Low	141.3
Low52	40.36
Low52 Date	2025-08-01
Low52ch	255.89%
Ma50ch	3.54%
Premarket Change Percent	-1.01
Premarket Price	$144
Premarket Volume	703
Price vs 200-day SMA	35.53%
RSI	45.28
RSI Monthly	70.24
RSI Weekly	66.28
Sharpe ratio	2.16x
Sortino ratio	4.17
Total Return	-3.2%
Tr YTD	40.61
Tr1m	-3.75%
Tr1w	-5.69%
Tr3m	62.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	25
Analyst Count Top	12
Analyst Price Target Top	$164
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.46
Earnings Revenue Estimate	314,898,640x
Earnings Revenue Estimate Growth	35.68x
Operating Income	$-447.1M
Operating margin	-41.39
Price target	$171
Price Target Change	$19.12
Price Target Change Top	$13.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	127,843,219%
Float Percent	96.41%
Net Borrowing	402,500,000
Shares Insiders	3.59%
Shares Institutions	103.82%
Shares Out	132,599,929
Shares Qo Q	2.03%
Shares Yo Y	3.2%
Short Float	8.93%
Short Ratio	3.28
Short Shares	8.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-413.2M
Adjusted OCF	-363,762,000
Average Volume	2,385,571.45x
Bv Per Share	-1.38
CAPEX	$-49.4M
Ch1m	-3.75
Ch1w	-5.69
Ch1y	223.3
Ch3m	62.28
Ch3y	283.9
Ch5y	30.97
Ch6m	25.33
Change	-1.27%
Change From Open	-1.23
Close	145.5
Days Gap	-0.04
Depreciation Amortization	38,942,000
Dollar Volume	226,838,598.3
Earnings Date	2026-07-30
Earnings Time	amc
EBIT	$-447.6M
EBITDA	$-408.6M
EPS	$-3.4
F Score	4
FCF	$-237.1M
FCF EV Yield	-1.21x
FCF Per Share	$-1.79
Financing CF	716,406,000
Fiscal Year End	December
Founded	2,011
Goodwill	77,257,000
Income Tax	$-1.2M
Investing CF	-230,648,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-19
Ma150	111.1
Ma150ch	29.3%
Ma20	156.5
Ma20ch	-8.26%
Net CF	297,588,000
Next Earnings Date	2026-07-30
Open	145.4
Optionable	Yes
Position In Range	36.01
Ppne	303,941,000
Pre Close	145.5
Price Date	2026-07-28
Relative Volume	0.66x
Revenue	1,080,215,000x
SBC By Revenue	16.3x
Share Based Comp	176,068,000
Tax By Revenue	-0.11x
Tr6m	25.33%
Us State	California
Volume	1,579,436
Z Score	0.82

Guardant Health, Inc. (GH)

Coverage state: Market snapshot only — no published research

Generate the first GH analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · GH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GH indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on GH

Frequently asked questions